185 related articles for article (PubMed ID: 26551887)
1. The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.
Tuttle TR; Mierzwa ML; Wells SI; Fox SR; Ben-Jonathan N
Cancer Lett; 2016 Jan; 370(2):279-85. PubMed ID: 26551887
[TBL] [Abstract][Full Text] [Related]
2. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.
Tuttle TR; Takiar V; Kumar B; Kumar P; Ben-Jonathan N
Cancer Lett; 2017 Mar; 389():33-40. PubMed ID: 28025101
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
Burley DS; Ferdinandy P; Baxter GF
Br J Pharmacol; 2007 Nov; 152(6):855-69. PubMed ID: 17700722
[TBL] [Abstract][Full Text] [Related]
5. Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
Califano JA; Khan Z; Noonan KA; Rudraraju L; Zhang Z; Wang H; Goodman S; Gourin CG; Ha PK; Fakhry C; Saunders J; Levine M; Tang M; Neuner G; Richmon JD; Blanco R; Agrawal N; Koch WM; Marur S; Weed DT; Serafini P; Borrello I
Clin Cancer Res; 2015 Jan; 21(1):30-8. PubMed ID: 25564570
[TBL] [Abstract][Full Text] [Related]
6. [Role of NO-cGMP-PKG axis in pulmonary arterial hypertension].
Watanabe H
Nihon Yakurigaku Zasshi; 2022; 157(4):221-225. PubMed ID: 35781448
[TBL] [Abstract][Full Text] [Related]
7. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
[TBL] [Abstract][Full Text] [Related]
8. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
9. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
[TBL] [Abstract][Full Text] [Related]
10. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
12. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
Ren Y; Zheng J; Yao X; Weng G; Wu L
Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
[TBL] [Abstract][Full Text] [Related]
13. Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway.
Ikuta T; Ausenda S; Cappellini MD
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1847-52. PubMed ID: 11172039
[TBL] [Abstract][Full Text] [Related]
14. G-substrate: the cerebellum and beyond.
Endo S
Prog Mol Biol Transl Sci; 2012; 106():381-416. PubMed ID: 22340725
[TBL] [Abstract][Full Text] [Related]
15. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Fallahian F; Karami-Tehrani F; Salami S; Aghaei M
FEBS J; 2011 Sep; 278(18):3360-9. PubMed ID: 21777390
[TBL] [Abstract][Full Text] [Related]
16. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the cGMP signalling pathway in the regulation of viability in insulin-secreting BRIN-BD11 cells.
Kaminski A; Gao H; Morgan NG
FEBS Lett; 2004 Feb; 559(1-3):118-24. PubMed ID: 14960318
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
[TBL] [Abstract][Full Text] [Related]
19. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
Lueptow LM; Zhan CG; O'Donnell JM
Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
